Lifeboat Foundation

Narrated by actor Edward James Olmos, this video describes one of the body’s critical anti-cancer defences – the telomeres. These caps on the ends of our chromosomes shorten each time a cell divides and, when they become too short, trigger the cell to self-destruct. When a cell grows too rapidly, it and all of its descendants normally suffer this fate. Such growths are sometimes called “pre-cancer”. Since our stem cells need to be able to divide without this constraint in order to replace cells lost across the body, they produce the enzyme telomerase to re-extend their telomeres. Unfortunately, a small number of pre-cancerous cells manage to activate their own copies of the telomerase gene, escaping the limit on their growth. SENS Research Foundation is developing therapies to completely block telomere extension in pre-cancerous cells, ensuring the body’s existing defences can function as intended.

Its painful to bear views that make many think I’m an imbicile and dislike me. So please, if anybody has a rational argument why any of this is wrong, I beg to be enlightened. I’ve set up a diagram for the purpose that will support you to add your criticism exactly where it is pertinent. https://tssciencecollaboration.com/graphtree/Are%20Vaccines%20Safe/406/4083

(1) The National Academy’s Reviews Of Vaccine Safety
The Institute of Medicine of the National Academies has provided several multi-hundred page surveys studying the safety of vaccines, but rather than reassuring, these itemize some iatrogenic conditions being caused, and pronounce the scientific literature inadequate to say whether most others are. The 2011 Institute of Medicine (IOM) Review[1] looked at 146 vaccine-condition pairs for causality, reporting:

• 14 for which the evidence is said to convincingly support causality, the vaccine is causing the condition.
• 4 where the evidence is said to favor acceptance.
• 5 where the evidence is said to favor rejection, including MMR causing autism.
• 123 where the evidence is said insufficient to evaluate.

The 2003 IOM Review on multiple vaccines said[2]:
“The committee was unable to address the concern that repeated exposure of a susceptible child to multiple immunizations over the developmental period may also produce atypical or non-specific immune or nervous system injury that could lead to severe disability or death (Fisher, 2001). There are no epidemiological studies that address this.”
and:
“the committee concludes that the epidemiological and clinical evidence is inadequate to accept or reject a causal relationship between multiple immunization and an increased risk of allergic disease, particularly asthma.”

• None of the IOM Safety Reviews[1][2][3][4] addressed the aluminum (for example whether the aluminum is causing autism), or mentioned contaminants, or discussed animal models although they had concluded as just quoted there is generally no epidemiological or clinical data worth preferring.

(2) The Aluminum.
Alum was added to vaccines back in the 1920’s, with no test of parenteral toxicity until recently[5], because it prods the immature immune system out of its normal operating range.[6] Maybe they figured aluminum is common in the environment, but injection bypasses half a dozen evolved sequential filters that normally keep it out of circulatory flow during development. Vaccines put hundreds of times as much aluminum into infants’ blood as they would otherwise get, and in an unnatural form that is hard for the body to remove.[7][8 (cfsec 4.2)][9]. The published empirical results indicate its highly toxic.

Continue reading “The Top Ten Reasons I Believe Vaccine Safety Is an Epic Mass Delusion” »

Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer’s disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging.

The study, which comes jointly from the Buck Institute for Research on Aging and the UCLA Easton Laboratories for Neurodegenerative Disease Research, is the first to objectively show that memory loss in patients can be reversed, and improvement sustained, using a complex, 36-point therapeutic personalized program that involves comprehensive changes in diet, brain stimulation, exercise, optimization of sleep, specific pharmaceuticals and vitamins, and multiple additional steps that affect brain chemistry.

“All of these patients had either well-defined mild cognitive impairment (MCI), subjective cognitive impairment (SCI) or had been diagnosed with AD before beginning the program,” said author Dale Bredesen, MD, a professor at the Buck Institute and professor at the Easton Laboratories for Neurodegenerative Disease Research at UCLA, who noted that patients who had had to discontinue work were able to return to work and those struggling at their jobs were able to improve their performance. “Follow up testing showed some of the patients going from abnormal to normal.”

Continue reading “Pre and post testing show reversal of memory loss from Alzheimer’s disease in 10 patients” »

Definitely been seeing great research and success in Biocomputing; why I have been looking more and more in this area of the industry. Bio/ medical technology is our ultimate future state for singularity. It is the key that will help improve the enhancements we need to defeat cancer, aging, intelligence enhance, etc. as we have already seen the early hints already of what it can do for people, machines and data, the environment and resources. However, a word of caution, DNA ownership and security. We will need proper governance and oversight in this space.

© iStock/ Getty Images undefined How much storage do you have around the house? A few terabyte hard drives? What about USB sticks and old SATA drives? Humanity uses a staggering amount of storage, and our needs are only expanding as we build data centers, better cameras, and all sorts of other data-heavy gizmos. It’s a problem scientists from companies like IBM, Intel, and Microsoft are trying to solve, and the solution might be in our DNA.

A recent Spectrum article takes a look at the quest to unlock the storage potential of human DNA. DNA molecules are the building blocks of life, piecing our genetic information into living forms. The theory is that we can convert digital files into biological material by translating it from binary code into genetic code. That’s right: the future of storage could be test tubes.

Continue reading “The future of storage may be in DNA” »

Elysium Health hasn’t discovered the fountain of youth, but their new supplement—with the backing of some of the world’s foremost authorities on aging—could change how you get older.

“People are increasingly living past 100. That means some big changes for the future of work”

Read more

My new Psychology Today story on BREXIT and the EU:

Scientific innovation doesn’t just happen on its own. It takes stable economies, free societies, and open-minded governments. The best environment for science to thrive in is that of collaborating groups incentivized to communicate and cooperate with one another. This is precisely what the European Union is.

And now, more than ever, the union of Europe is needed—because we are crossing over into the transhumanist age, where radical science and technology will engulf our lives and challenge our institutions. Robots will take 75% of the jobs in the next 25 years. CRISPR gene editing technology will allow us to augment our intelligence, perhaps doubling our IQ. Bionic organs will stave off death, allowing 200 year lifespans.

Continue reading “Scientific Innovation Needs the European Union to Succeed” »

An anti-aging drug is about to begin human trials.

Washington University in St. Louis and Keio University in Japan is set to test the effectiveness and safety of the compound. Starting next month, about 10 healthy people will be administered NMN to see if can improve bodily function and stave off the effects of aging. Should it work, it would become the first bona fide anti-aging intervention available on the market.

A compound called nicotinamide mono nucleotide (NMN) has been shown to slow down the aging process and extend the lifespans of mice. We’re about to find out if it does the same thing to humans.

A planned clinical trial devised by researchers from Washington University in St. Louis and Keio University in Japan is set to test the effectiveness and safety of the compound. Starting next month, about 10 healthy people will be administered NMN to see if can improve bodily function and stave off the effects of aging. Should it work, it would become the first bona fide anti-aging intervention available on the market.

Continue reading “A Promising Anti-Aging Drug Will Soon Be Tried On Humans” »